Dosing<i>de novo</i>combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers
-
- Sariah Liu
- Department of Hematology-Oncology, Kaiser Permanente San Diego Medical Center, San Diego, CA, USA
-
- Mina Nikanjam
- Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, CA, USA
-
- Razelle Kurzrock
- Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UC San Diego Moores Cancer Center, San Diego, CA, USA
収録刊行物
-
- Oncotarget
-
Oncotarget 7 (10), 11310-11320, 2016-01-25
Impact Journals, LLC